BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15563744)

  • 1. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
    Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
    Jensen MP
    Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.
    Gammaitoni AR; Galer BS; Onawola R; Jensen MP; Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S13-9. PubMed ID: 15563742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
    Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
    Jensen MP; Dworkin RH; Gammaitoni AR; Olaleye DO; Oleka N; Galer BS
    J Pain; 2005 Feb; 6(2):98-106. PubMed ID: 15694876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.
    Nayak S; Cunliffe M
    Paediatr Anaesth; 2008 Jun; 18(6):554-8. PubMed ID: 18363625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response.
    Fishbain DA; Lewis JE; Cole B; Cutler B; Rosomoff HL; Rosomoff RS
    Pain Med; 2006; 7(2):135-42. PubMed ID: 16634726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis.
    Galer BS; Sheldon E; Patel N; Codding C; Burch F; Gammaitoni AR
    Curr Med Res Opin; 2004 Sep; 20(9):1455-8. PubMed ID: 15383194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
    Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
    Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.
    Galer BS; Jensen MP; Ma T; Davies PS; Rowbotham MC
    Clin J Pain; 2002; 18(5):297-301. PubMed ID: 12218500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
    Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
    Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.
    Tremont-Lukats IW; Hutson PR; Backonja MM
    Clin J Pain; 2006; 22(3):266-71. PubMed ID: 16514327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
    Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
    Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases.
    Hans G; Joukes E; Verhulst J; Vercauteren M
    Curr Med Res Opin; 2009 Nov; 25(11):2737-43. PubMed ID: 19788351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome.
    Jensen MP; Gammaitoni AR; Olaleye DO; Oleka N; Nalamachu SR; Galer BS
    J Pain; 2006 Nov; 7(11):823-32. PubMed ID: 17074624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream].
    Iseki M; Mitsuhata H; Miyazaki T; Toriumi E; Yoshino K
    Masui; 2000 Nov; 49(11):1204-9. PubMed ID: 11215225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.